150 related articles for article (PubMed ID: 3190814)
1. Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration.
Steinijans VW; Trautmann H; Sauter R; Staudinger H
Arzneimittelforschung; 1988 Aug; 38(8A):1251-3. PubMed ID: 3190814
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
Steinijans VW; Sauter R; Böhm A; Staudinger H
Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Götz J; Sauter R; Steinijans VW; Jonkman JH
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
[TBL] [Abstract][Full Text] [Related]
4. Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin).
Steinijans VW; Schulz HU; Beier W; Radtke HW
Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):438-47. PubMed ID: 3759279
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
6. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
[TBL] [Abstract][Full Text] [Related]
7. Euphylong. A new sustained-release theophylline pellet formulation for once-daily evening administration.
Arzneimittelforschung; 1988 Aug; 38(8A):1199-256. PubMed ID: 3190807
[No Abstract] [Full Text] [Related]
8. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage].
Keinke O
Arzneimittelforschung; 1989 Nov; 39(11):1460-4. PubMed ID: 2619780
[TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
11. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
[TBL] [Abstract][Full Text] [Related]
13. Effect of drug intake prior to or after meals on serum theophylline concentrations: single-dose studies with Euphylong.
Schulz HU; Karlsson S; Sahner-Ahrens I; Steinijans VW; Beier W
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):222-8. PubMed ID: 3583472
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
Trnavská Z; Vondra V; Elis J
Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
18. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
20. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
Cova D; Cuglituri G; Rossini L; Bonfardeci G
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
